European Commission Grants Approval of Remsima™ IV Liquid Formulation, World’s First Liquid Formulation of IV Infliximab

Celltrion, Inc. today announced that the European Commission (EC) has granted marketing authorization for Remsima™ IV (intravenous) liquid formulation, the world’s first liquid formulation of IV ...
Contract Pharma

European Commission Approves Remsima IV Liquid Formulation

Celltrion announced that the European Commission (EC) has granted marketing authorization for Remsima IV (intravenous) liquid formulation, the world’s first liquid formulation of IV infliximab.

European Commission Grants Approval of Remsima(TM) IV Liquid Formulation, World's First Liquid Formulation of IV Infliximab

The MarketWatch News Department was not involved in the creation of this content.-- Remsima(TM) IV (intravenous) liquid formulation, the world's first liquid formulation of IV inf ...